“Estimating the Budget Impact of Innovative Pharmacological Treatments for Patients With Type 2 Diabetes Mellitus in Italy: The Case of Liraglutide (GLP-1). ”. 2022. Epidemiology, Biostatistics, and Public Health 12 (2). https://doi.org/10.2427/11082.